Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Baltimore, Maryland 21201


Purpose:

Diabetes and its associated complications affect more than 20 million Americans, and the prevalence of type 2 diabetes and impaired glucose tolerance rises dramatically with age such that 40% of Americans over age 60 are affected. In older adults, glucose metabolism may be affected by reduced skeletal muscle capillary supply, which limits insulin, glucose, and oxygen delivery to skeletal muscle. Reduced capillary supply to skeletal muscle is found in older individuals with impaired glucose tolerance and we hypothesize that this is due to reduced vascular growth factor expression, and chronic inflammation. Further, we hypothesize that reversal of a sedentary lifestyle through aerobic exercise training will increase insulin signaling and vascular growth factor expression, as well as decrease inflammation, to increase capillary supply to skeletal muscle, which contributes to improved glucose metabolism in older adults with IGT. This study will: 1) Determine the mechanisms underlying reduced skeletal muscle capillarization in older adults with impaired glucose tolerance; and 2) Determine the effect of aerobic exercise training-induced increases in skeletal muscle capillarization on glucose metabolism in older adults with impaired glucose tolerance.


Criteria:

Inclusion Criteria: - Age 50-75 years - Non-smoker >2 years - Body mass index = 18-35 kg/m2 Exclusion Criteria: - History of CAD or cerebrovascular disease that would preclude exercise - Implantable defibrillator - Active cancer - Chronic pulmonary, thyroid, renal, liver, or hematological disease - HIV positive or prone to malnutrition - Sickle cell anemia - Type 1 diabetes, or currently on medication to treat type 2 diabetes - Poorly-controlled type 2 diabetes - Poorly-controlled hypertension - Taking medications including: beta-blockers, oral steroids, warfarin, certain statins, hormone replacement therapy (HRT), oral contraceptives (OCP), thiazolidinediones (TZD), or chronic steroids or nonsteroidal analgesics (NSAIDS) that may not be safely discontinued temporarily for specific procedures (i.e. for 72 hours prior) - Allergic to lidocaine or heparin - Recent weight change (>5kg in 3 months) - Currently pregnant or nursing - Physical impairment limiting exercise - Dementia or unstable clinical depression


NCT ID:

NCT00701051


Primary Contact:

Principal Investigator
Steven J. Prior, PhD
VA Maryland Health Care System, Baltimore


Backup Contact:

N/A


Location Contact:

Baltimore, Maryland 21201
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: January 21, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.